Skip to main content
. 2021 May 7;11:9690. doi: 10.1038/s41598-021-89251-y

Table 1.

Descriptive table of the study participants and comparisons between psychiatric patients and healthy controls.

Total study population (N = 218) Healthy controls (n = 46) Psychiatric patients (n = 172)
General characteristics
Sex: Female, n (%) 168 (77) 36 (78) 132 (77)
Age, years, median (IQR) 21.00 (3.00) 22.00 (3.00) 21.00 (4.00)***
Smoking, n (%)b 52 (24) 1 (2) 51 (30)***
Educational level: University, n (%) 127 (58) 45 (98) 82 (48)***
Psychiatric characteristics
Neuroticism score, mean (SD) 59.10 (8.75) 50.39 (5.92) 61.43 (7.88)***
Antidepressants, n (%)a 82 (38) 0 (0) 82 (48)***
Any anxiety disorder, n (%) 108 (50) 0 (0) 108 (63)***
Current MDD, n (%) 74 (34) 0 (0) 74 (43)***
Life-time unipolar depressive episode, n (%) 124 (57) 3 (7) 121 (70)***
Bipolar disorder, n (%) 27 (12) 0 (0) 27 (16)**
Substance addiction, n (%) 16 (7) 0 (0) 16 (9)*
Somatic status
BMI, kg/m2, median (IQR)c 22.41 (4.80) 22.38 (2.67) 22.49 (5.63)
WHR, median (IQR)d 0.76 (0.08) 0.74 (0.07) 0.76 (0.08)**
SBP, mmHg, median (IQR)e 119.00 (10.00) 110.00 (15.00) 120.00 (10.00)*
DBP, mmHg, median (IQR)e 70.00 (5.00) 70.00 (10.00) 65.50 (5.00)*
Biomarkers of interest
L/A ratio, median (IQR) 1.35 (2.09) 1.17 (1.19) 1.47 (2.37)
Leptin, ng/mL, median (IQR) 14.00 (17.46) 11.48 (12.13) 16.31 (20.85)*
Adiponectin, ug/mL, median (IQR) 9.45 (4.49) 9.36 (4.09) 9.45 (4.69)
CRP, mg/L, median (IQR)f 0.79 (2.10) 0.46 (0.64) 1.00 (2.51)*
IL-6, pg/mL, median (IQR)f 0.29 (0.34) 0.23 (0.22) 0.33 (0.37)**
TNF-α, pg/mL, median (IQR)f 1.86 (1.02) 1.91 (0.97) 1.85 (1.18)

To test if there was a significant difference between patients and controls, the Chi-square test (or Fisher’s test when applicable) was used for the categorical variables and the Mann–Whitney test for the continuous variables.

IQR interquartile range, BMI body mass index, WHR Waist-hip ratio, SBP systolic blood pressure, DBP diastolic blood pressure, L/A leptin/adiponectin.

*p < 0.05, **p < 0.01, ***p < 0.001.

aSSRI, SNRI, tricylic antidepressants, Mirtazapine, Mianserin or Buproprion.

Missing data for: bFourteen controls and forty-nine patients; cFour patients; dThirteen patients and two controls; eTwo patients; fSixteen patients.